Around 1.7 million women are diagnosed with breast cancer world-wide each year, with more than 15,000 women and over 100 men affected in Australia. Of these, around one in four will need repeat surgery to remove tumour cells, often missed in the initial surgery. Microscope-in-a-Needle is a highly miniaturised medical device that fits inside a needle and is capable of detecting cancer cells with high resolution 3D imaging. The Optical Micro-Elastography device will image the stiffness of malignant tissue at a microscopic level, allowing surgeons to feel whether all the tumour is gone. Both devices will be commercialised for theatre use and will significantly improve detection and removal of tumour tissue and reduce or eliminate the need for repeat surgery. These technologies will impact the lives of women and men world-wide.
Category: Medicine, Dentistry and Health Sciences
In Australia, 22 percent of surgeries suffer from an ‘adverse event’. Whilst most events are minor and cause no permanent harm, 13 percent result in some form of disability 18 months later. 48 percent of these adverse events are preventable and as many as 70 percent are due to communication failures. Added to this are growing hospital wait lists and an ageing population. Public hospitals are now looking to implement efficiencies that can relieve the pressure. The SWANS team have come up with a simple, yet fresh approach of introducing pre-surgical briefings to operating theatres, and their pilot studies have already demonstrated very promising results.